资讯

Zacks Small Cap Research on MSN1 小时
ENSC Start Phase 3 Trial on Abuse-Resistant Pain Reliever
ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the ...
A new Texas law that will provide up to $50 million to study ibogaine reflects growing government interest in psychedelic ...
Deaths by natural causes (275 deaths) far outweighed deaths by unnatural causes, such as accidental deaths (42), suicides (9), and homicides (0). Nevertheless, accidental deaths involving drugs and ...
Unlike alcohol, which has a long-established legal limit (0.08% BAC) and near-instant results from breathalyzers, THC and other drugs don’t behave the same way in the body. THC can linger in the ...
Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs ...
Self-help groups and medications (buprenorphine, methadone, and naltrexone) both play important roles in opioid addiction treatment. The relative use of these two treatment modalities has not been ...
Chronic pain, which lasts for three months or longer, is difficult to treat. Many people rely on opioid pain medications, but these drugs are controversial. While they can help manage pain, they ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they remain underutilised, says Rong Xu, PhD, professor at Case Western Reserve ...
An Effective Treatment for Opioid Addiction Exists. Why Isn’t It Used More? A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis.
A new, non-opioid pain drug is here. Getting it to patients could be agony. After decades of research, Vertex Pharmaceuticals has an approved pain medicine. Can one of the most powerful biotechs ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.